Introduction
Glucocorticosteroids have been shown clinically to exert a dramatic effect on certain types of brain oedema of vasogenic origin, i.e. brain oedema that has been caused by leakage of blood plasma into brain tissue due to breakdown of the blood-brain barrier. In this respect, vasogenic brain oedema resembles the inflammatory exudate in other parts of the body, which in inflammatory lesions results from the increase of vascular permeability. Blood-brain barrier disruption often accompanies brain tumours, traumatic lacerations, haemorrhages and infarctions, and therefore brain oedema has a considerable clinical significance, especially in view of the restricted expansive capacity of the head, contributing to morbidity and eventual mortality. 2, 3 
Results
In the untreated, animals LCT-1 immunoreactivity could not be observed in the greater part of the brain, but only in sporadic cells, which are probably of microglial nature (Fig. 1) . The choroid plexus showed a faint reaction (not shown). LCT-2 immunostaining was similar although less pronounced.
The rats pretreated with methylprednisolone showed widespread LCT-1 immunoreactivity in neurones, especially in those of the hippocampus, and probably also in astrocytes as well as in microglial cells (Fig. 2) . Also, the choroid plexus showed LCT-1 immunoreactivity.
Oligodendrocytes as well as capillary endothelial cells were devoid of reaction product. LCT-2 immunostaining was less pronounced in the nervous parenchyma, but was well demonstrable in the choroid plexus and the leptomeninges (Fig. 3) . LCT-2 immunoreactivity was far less pronounced than the reactivity to LCT-1, with the strongest reaction seen in the meninges. The immunoreactivity to LCT-5 was similar to that of LCT-1, being exhibited most by microglia, the leptomeninges and also by some blood vessels.
Pretreatment with the 21-aminosteroid gave the strongest LCT-1 immunoreactivity in cortical neurones, oligodendrogial cells of the white matter (Fig.   4 ), ventricular ependyma (Fig. 5 ) and choroid plexus (Fig. 6) . After the 21-aminosteroid pretreatment LCT-2 immunoreactivity was evident also in cortical neurones (Fig. 7) , capillary endothelium, meningeal cells and ventricular ependyma. The controls incubated with PBS were all negative. Although the 21-aminosteroids have been reported to exert no action upon glucose metabolism, they had a strong effect in inducing LCT formation. In the present study the steroids were administered 1 day and 2 h prior to the experiment. Where dexamethasone had been administered to the animals only 2 h before termination, the pattern of LCT immunoreactivity was not different from that in untreated animals in that it was only observed in certain regions, being absent in the larger part of the brain. 13 Although lately the effect of glucocorticosteroids in suppressing eicosanoid formation has been questioned in a number of cell types, the effect has been confirmed in macrophages, 14, 15 to which the microglia of the central nervous system may be considered similar. It may be concluded that there is little spontaneous LCT immunoreactivity in the brain paren-chyma, and that glucocortico-and 21-aminosteroids can induce LCT formation in the brain parenchyma, and may in this way mediate the effects of steroids in brain oedema.
